The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Value of clinical treatment score post-5 years (CTS5) for late relapse risk assessment in patients with early-stage HER2+ breast cancer (BC) in the north central cancer treatment group (NCCTG) N9831 (Alliance) trial.
 
Tanmayi Pai
No Relationships to Disclose
 
Angelica Gil
No Relationships to Disclose
 
Yaohua Ma
No Relationships to Disclose
 
Zhuo Li
No Relationships to Disclose
 
Pooja Advani
No Relationships to Disclose
 
Alvaro Moreno-Aspitia
Stock and Other Ownership Interests - Merrimack
Patents, Royalties, Other Intellectual Property - Royalties from the development of a xenograft model. Royalties were assigned to go to my institution and not personally
 
Gerardo Colon-Otero
Research Funding - Novartis (Inst)
 
Edith A. Perez
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
Consulting or Advisory Role - Daiichi Sankyo; Puma Biotechnology; Seagen
Research Funding - bioTheranostics (Inst); Genentech (Inst); Genomic Health (Inst); GlaxoSmithKline (Inst); LabCorp (Inst); Novartis (Inst)
 
E Aubrey Thompson
No Relationships to Disclose
 
Saranya Chumsri
Consulting or Advisory Role - Eisai; Immunomedics; Novartis; Puma Biotechnology; Syndax
Research Funding - Array BioPharma; Merck